ABSTRACT
Natural products are, without challenge, the richest resource of chemical diversity. Theoretically, their efficient use can provide the optimum opportunity for the discovery of new bioactive substances in a high throughput screening (HTS) program. Practically, such use carries with it logistic and technological demands that are often beyond the capabilities and budgets assigned. Small start-up companies are especially susceptible to these barriers unless their initial organization has specifically targeted this approach.
